CUV 2.61% $22.42 clinuvel pharmaceuticals limited

company presentation

  1. 4,711 Posts.
    lightbulb Created with Sketch. 24
    I looked over their company presentation they have achieved and it is inevitable as mentioned in the report that a Big Phar Company will seek to partner with and already they have been approached by companies regarding the Melanotan. They are seeking FDA approval next month, which will be another boost. I dont see them seeking extra funds as they mentioned they will commercialise their developement through a partnership. The company has NO Borrowings and Debt and shares on issue is small considering other Biotec companies. And they have a world patent rights which means no competion. Looks good to me. This stock is bound to reach over the $1.00 mark again and I feel confident that will go even further in share price. Anothe good Aussie invention.

watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Mkt cap $1.045B
Open High Low Value Volume
$22.00 $22.42 $21.83 $1.800M 81.39K

Buyers (Bids)

No. Vol. Price($)
1 344 $22.28

Sellers (Offers)

Price($) Vol. No.
$22.44 102 1
Last update - 16.10pm 16/01/2019 (20 minute delay) ?
0.57 ( 2.16 %)
Open High   Low Volume
$22.10 $22.40   $21.89 1025
Last updated 15.59pm 16/01/2019 (live) ?
CUV (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.